T A Hoeven1, M J G Leening2, P J Bindels3, M Castaño-Betancourt4, J B van Meurs5, O H Franco6, M Kavousi6, A Hofman6, M A Ikram7, J C M Witteman6, S M Bierma-Zeinstra8. 1. Department of General Practice, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands. 3. Department of General Practice, Erasmus University Medical Center, Rotterdam, The Netherlands. 4. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. 5. Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. 6. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands. 7. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands. 8. Department of General Practice, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Orthopaedics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Abstract
BACKGROUND: Previous studies found an association between osteoarthritis (OA) and risk of cardiovascular disease (CVD) and therefore suggested intensive treatment of cardiovascular risk factors in OA patients. However, prospective population-based data is lacking. OBJECTIVES: To investigate the association between OA and CVD longitudinally in a general population and examine the role of disability in this association. METHODS: This study was embedded in the Rotterdam Study, a prospective population-based cohort study in Rotterdam, the Netherlands that started in 1989. At baseline 4648 persons aged ≥55, free of CVD were classified into those with and those without radiographic or clinical OA. HRs adjusted for traditional cardiovascular risk factors for developing CVD (a composite of fatal and non-fatal coronary heart disease and stroke) were calculated. RESULTS: During a median follow-up of 14.4 years, 1230 cardiovascular events occurred, of which 101 were in participants with clinical OA. Presence of radiographic OA at baseline was not related to future CVD (HR 0.99, 95% CI 0.86 to 1.15), neither was presence of clinical OA (HR 1.09, 95% CI 0.88 to 1.34). However, persons with increasing disability were more likely to suffer a cardiovascular event compared with non-disabled persons (HR 1.26, 95% CI 1.12 to 1.42); this was independent of the presence of OA. CONCLUSIONS: In this large population-based study, participants with OA were not at increased risk of CVD. The close relation between disability and osteoarthritis may explain previous findings. Further studies are required in order to clarify whether OA patients need more intensive treatment of their cardiovascular risk factors. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: Previous studies found an association between osteoarthritis (OA) and risk of cardiovascular disease (CVD) and therefore suggested intensive treatment of cardiovascular risk factors in OA patients. However, prospective population-based data is lacking. OBJECTIVES: To investigate the association between OA and CVD longitudinally in a general population and examine the role of disability in this association. METHODS: This study was embedded in the Rotterdam Study, a prospective population-based cohort study in Rotterdam, the Netherlands that started in 1989. At baseline 4648 persons aged ≥55, free of CVD were classified into those with and those without radiographic or clinical OA. HRs adjusted for traditional cardiovascular risk factors for developing CVD (a composite of fatal and non-fatal coronary heart disease and stroke) were calculated. RESULTS: During a median follow-up of 14.4 years, 1230 cardiovascular events occurred, of which 101 were in participants with clinical OA. Presence of radiographic OA at baseline was not related to future CVD (HR 0.99, 95% CI 0.86 to 1.15), neither was presence of clinical OA (HR 1.09, 95% CI 0.88 to 1.34). However, persons with increasing disability were more likely to suffer a cardiovascular event compared with non-disabled persons (HR 1.26, 95% CI 1.12 to 1.42); this was independent of the presence of OA. CONCLUSIONS: In this large population-based study, participants with OA were not at increased risk of CVD. The close relation between disability and osteoarthritis may explain previous findings. Further studies are required in order to clarify whether OA patients need more intensive treatment of their cardiovascular risk factors. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij Journal: Eur J Epidemiol Date: 2015-09-19 Impact factor: 8.082
Authors: Marcia L Stefanick; Robert L Brunner; X Leng; Marian C Limacher; Chloe E Bird; David O Garcia; Patricia E Hogan; Michael J LaMonte; Rachel H Mackey; Karen C Johnson; Andrea LaCroix; Jennifer G Robinson; Rebecca A Seguin; Hilary A Tindle; Sylvia Wassertheil-Smoller Journal: J Gerontol A Biol Sci Med Sci Date: 2016-03 Impact factor: 6.053
Authors: Kamil E Barbour; Li-Yung Lui; Michael C Nevitt; Louise B Murphy; Charles G Helmick; Kristina A Theis; Marc C Hochberg; Nancy E Lane; Jennifer M Hootman; Jane A Cauley Journal: Arthritis Rheumatol Date: 2015-07 Impact factor: 10.995
Authors: Eric J Roseen; Michael P LaValley; Shanshan Li; Robert B Saper; David T Felson; Lisa Fredman Journal: J Gen Intern Med Date: 2018-10-22 Impact factor: 5.128
Authors: Elizabeth A Schlenk; Joni Vander Bilt; Wei-Hsuan Lo-Ciganic; Mini E Jacob; Sarah E Woody; Molly B Conroy; C Kent Kwoh; Steven M Albert; Robert Boudreau; Anne B Newman; Janice C Zgibor Journal: Res Gerontol Nurs Date: 2015-10-26 Impact factor: 1.571